Condizione: New.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 184,82
Quantità: 10 disponibili
Aggiungi al carrelloCondizione: New.
EUR 207,22
Quantità: 1 disponibili
Aggiungi al carrelloHRD. Condizione: New. New Book. Shipped from UK. Established seller since 2000.
HRD. Condizione: New. New Book. Shipped from UK. Established seller since 2000.
Condizione: As New. Unread book in perfect condition.
EUR 188,77
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: NEW.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 219,59
Quantità: 10 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
EUR 218,11
Quantità: 1 disponibili
Aggiungi al carrellohardcover. Condizione: New.
EUR 234,73
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
Condizione: New.
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
Prima edizione
EUR 250,12
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: New. 2025. 1st Edition. hardcover. . . . . .
Lingua: Inglese
Editore: Apple Academic Press Inc., CA, 2025
ISBN 10: 1998511804 ISBN 13: 9781998511808
Da: Rarewaves.com USA, London, LONDO, Regno Unito
EUR 277,84
Quantità: 1 disponibili
Aggiungi al carrelloHardback. Condizione: New. Tuberculosis is a major global health threat even today, claiming the lives of millions each year, despite the availability of effective treatments for the disease. The emergence of drug resistance and limitations of existing therapies demand the continuous development of new and improved drugs. This new book provides a comprehensive overview of the latest progress in this field, covering state-of-the-art approaches to untangle the complexities of drug resistance.The book explores diagnosis methods, drug resistance mechanisms, and limitations in existing drugs and proposes strategies such as structural modifications, efflux pathway targeting, and host-directed therapies to overcome resistance. It also looks at artificial intelligence for TB management. Recent advancements in tuberculosis control, vaccine development, and biomarkers are also covered along with visions for the future of TB drug discovery, offering a glimpse into the evolving landscape of combating tuberculosis.
EUR 264,10
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
Condizione: New. 2025. 1st Edition. hardcover. . . . . . Books ship from the US and Ireland.
Lingua: Inglese
Editore: Apple Academic Press Inc., CA, 2025
ISBN 10: 1998511804 ISBN 13: 9781998511808
Da: Rarewaves.com UK, London, Regno Unito
EUR 263,28
Quantità: 1 disponibili
Aggiungi al carrelloHardback. Condizione: New. Tuberculosis is a major global health threat even today, claiming the lives of millions each year, despite the availability of effective treatments for the disease. The emergence of drug resistance and limitations of existing therapies demand the continuous development of new and improved drugs. This new book provides a comprehensive overview of the latest progress in this field, covering state-of-the-art approaches to untangle the complexities of drug resistance.The book explores diagnosis methods, drug resistance mechanisms, and limitations in existing drugs and proposes strategies such as structural modifications, efflux pathway targeting, and host-directed therapies to overcome resistance. It also looks at artificial intelligence for TB management. Recent advancements in tuberculosis control, vaccine development, and biomarkers are also covered along with visions for the future of TB drug discovery, offering a glimpse into the evolving landscape of combating tuberculosis.
EUR 333,91
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 462 pages. 9.18x6.12x10.00 inches. In Stock.
Lingua: Inglese
Editore: Apple Academic Press Inc., Oakville, 2025
ISBN 10: 1998511804 ISBN 13: 9781998511808
Da: Grand Eagle Retail, Bensenville, IL, U.S.A.
Hardcover. Condizione: new. Hardcover. Tuberculosis is a major global health threat even today, claiming the lives of millions each year, despite the availability of effective treatments for the disease. The emergence of drug resistance and limitations of existing therapies demand the continuous development of new and improved drugs. This new book provides a comprehensive overview of the latest progress in this field, covering state-of-the-art approaches to untangle the complexities of drug resistance.The book explores diagnosis methods, drug resistance mechanisms, and limitations in existing drugs and proposes strategies such as structural modifications, efflux pathway targeting, and host-directed therapies to overcome resistance. It also looks at artificial intelligence for TB management. Recent advancements in tuberculosis control, vaccine development, and biomarkers are also covered along with visions for the future of TB drug discovery, offering a glimpse into the evolving landscape of combating tuberculosis. Covers topics, from drug resistance to using AI to enhance treatment methods for TB. Explore TB diagnosis methods, drug resistance mechanisms in TB, and limitations in existing drugs and proposes strategies such as structural modifications, efflux pathway targeting, and host-directed therapies to overcome resistance. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Lingua: Inglese
Editore: Apple Academic Press Inc., Oakville, 2025
ISBN 10: 1998511804 ISBN 13: 9781998511808
Da: CitiRetail, Stevenage, Regno Unito
EUR 184,83
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: new. Hardcover. Tuberculosis is a major global health threat even today, claiming the lives of millions each year, despite the availability of effective treatments for the disease. The emergence of drug resistance and limitations of existing therapies demand the continuous development of new and improved drugs. This new book provides a comprehensive overview of the latest progress in this field, covering state-of-the-art approaches to untangle the complexities of drug resistance.The book explores diagnosis methods, drug resistance mechanisms, and limitations in existing drugs and proposes strategies such as structural modifications, efflux pathway targeting, and host-directed therapies to overcome resistance. It also looks at artificial intelligence for TB management. Recent advancements in tuberculosis control, vaccine development, and biomarkers are also covered along with visions for the future of TB drug discovery, offering a glimpse into the evolving landscape of combating tuberculosis. Covers topics, from drug resistance to using AI to enhance treatment methods for TB. Explore TB diagnosis methods, drug resistance mechanisms in TB, and limitations in existing drugs and proposes strategies such as structural modifications, efflux pathway targeting, and host-directed therapies to overcome resistance. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Da: Revaluation Books, Exeter, Regno Unito
EUR 269,85
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 462 pages. 9.18x6.12x10.00 inches. In Stock. This item is printed on demand.
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 245,12
Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Covers topics, from drug resistance to using AI to enhance treatment methods for TB. Explore TB diagnosis methods, drug resistance mechanisms in TB, and limitations in existing drugs and proposes strategies such as structural modifications, efflux pathway targeting, and host-directed therapies to overcome resistance.
Lingua: Inglese
Editore: Apple Academic Press Inc., Oakville, 2025
ISBN 10: 1998511804 ISBN 13: 9781998511808
Da: AussieBookSeller, Truganina, VIC, Australia
EUR 337,26
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: new. Hardcover. Tuberculosis is a major global health threat even today, claiming the lives of millions each year, despite the availability of effective treatments for the disease. The emergence of drug resistance and limitations of existing therapies demand the continuous development of new and improved drugs. This new book provides a comprehensive overview of the latest progress in this field, covering state-of-the-art approaches to untangle the complexities of drug resistance.The book explores diagnosis methods, drug resistance mechanisms, and limitations in existing drugs and proposes strategies such as structural modifications, efflux pathway targeting, and host-directed therapies to overcome resistance. It also looks at artificial intelligence for TB management. Recent advancements in tuberculosis control, vaccine development, and biomarkers are also covered along with visions for the future of TB drug discovery, offering a glimpse into the evolving landscape of combating tuberculosis. Covers topics, from drug resistance to using AI to enhance treatment methods for TB. Explore TB diagnosis methods, drug resistance mechanisms in TB, and limitations in existing drugs and proposes strategies such as structural modifications, efflux pathway targeting, and host-directed therapies to overcome resistance. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
Da: preigu, Osnabrück, Germania
EUR 304,65
Quantità: 5 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Recent Advancements in Tuberculosis Drug Discovery | Vivek P. Chavda (u. a.) | Buch | Einband - fest (Hardcover) | Englisch | 2025 | Apple Academic Press | EAN 9781998511808 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.